This is not a reason to change medication
WHO is currently working on a rapid advice guideline on possible use of GLP-1 RAs, including semaglutides, for treatment of obesity in adults and as part of a more comprehensive model of care
That said, some patients do experience mild stimulant-like effects from the bupropion component, including increased energy, reduced appetite, and occasionally insomnia
Highly recommend!p reanaTrustindex verifies that the original source of the review is Google.Rita is always providing the best care
These effects occur without elevating IGF-1 or affecting carbohydrate metabolism, differentiating it from full-length HGH in terms of safety and selectivity
Semaglutide is a safe and effective treatment when used for FDA licensed indications